DOCSLIB.ORG

Controlled Substances - Alphabetical Order

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Controlled Substances - Alphabetical Order Controlled Substances - Alphabetical Order - DEA CSA SUBSTANCE NUMBER SCH NARC OTHER NAMES 1-(1-Phenylcyclohexyl)pyrrolidine 7458 I N PCPy, PHP, rolicyclidine 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine 9663 I Y PEPAP, synthetic heroin 1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I N TCP, tenocyclidine 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 I N TCPy 13Beta-ethyl-17beta-hydroxygon-4-en-3-one 4000 III N 17Alpha-methyl-3alpha,17beta-dihydroxy-5alpha- 4000 III N androstane 17Alpha-methyl-3beta,17beta-dihydroxy-5alpha- 4000 III N androstane 17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene 4000 III N 17Alpha-methyl-4-hydroxynandrolone (17alpha-methyl- 4000 III N 4-hydroxy-17beta-hydroxyestr-4-en-3-one) 17Alpha-methyl-delta1-dihydrotestosterone (17beta- 4000 III N 17-Alpha-methyl-1-testosterone hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) 19-Nor-4,9(10)-androstadienedione 4000 III N 19-Nor-4-androstenediol (3beta,17beta-dihydroxyestr-4- 4000 III N ene; 3alpha,17beta-dihydroxyestr-4-ene) 19-Nor-4-androstenedione (estr-4-en-3,17-dione) 4000 III N 19-Nor-5-androstenediol (3beta,17beta-dihydroxyestr-5- 4000 III N ene; 3alpha,17beta-dihydroxyestr-5-ene) 19-Nor-5-androstenedione (estr-5-en-3,17-dione) 4000 III N 1-Androstenediol (3beta,17beta-dihydroxy-5alpha- 4000 III N androst-1-ene; 3alpha,17beta-dihydroxy-5alpha- androst-1-ene) 1-Androstenedione (5alpha-androst-1-en-3,17-dione) 4000 III N 1-Methyl-4-phenyl-4-propionoxypiperidine 9661 I Y MPPP, synthetic heroin 1-Phenylcyclohexylamine 7460 II N PCP precursor 1-Piperidinocyclohexanecarbonitrile 8603 II N PCC, PCP precursor 2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET 2,5-Dimethoxyamphetamine 7396 I N DMA, 2,5-DMA 2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) 7519 I N 2C-C 2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) 7508 I N 2C-D 2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) 7509 I N 2C-E 2C-H (2-(2,5-Dimethoxyphenyl) ethanamine) 7517 I N 2C-H 2C-I (2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine) 7518 I N 2C-I 2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) 7521 I N 2C-N 2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I N 2C-P ethanamine) Controlled Substances - Alphabetical Order 4/25/2013 Page 1 of 12 DEA CSA SUBSTANCE NUMBER SCH NARC OTHER NAMES 2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I N 2C-T-2 ethanamine) 2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I N 2C-T-4 ethanamine) 2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine) 7348 I N 2C-T-7 3,4,5-Trimethoxyamphetamine 7390 I N TMA 3,4-Methylenedioxyamphetamine 7400 I N MDA, Love Drug 3,4-Methylenedioxymethamphetamine 7405 I N MDMA, Ecstasy, XTC 3,4-Methylenedioxy-N-ethylamphetamine 7404 I N N-ethyl MDA, MDE, MDEA 3Alpha,17beta-dihydroxy-5alpha-androstane 4000 III N 3Beta,17beta-dihydroxy-5alpha-androstane 4000 III N 3-Methylfentanyl 9813 I Y China White, fentanyl 3-Methylthiofentanyl 9833 I Y Chine White, fentanyl 4-Androstenediol (3beta,17beta-dihydroxy-androst-4- 4000 III N 4-AD ene) 4-Androstenedione (androst-4-en-3,17-dione) 4000 III N 4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II N ANPP 4-Bromo-2,5-dimethoxyamphetamine 7391 I N DOB, 4-bromo-DMA 4-Bromo-2,5-dimethoxyphenethylamine 7392 I N 2C-B, Nexus, has been sold as Ecstasy, i.e. MDMA 4-Dihydrotestosterone (17beta-hydroxyandrostan-3- 4000 III N Anabolex, Andractim, Pesomax, Stanolone one) 4-Hydroxy-19-nortestosterone (4,17beta-dihydroxyestr- 4000 III N 4-en-3-one) 4-Hydroxytestosterone (4,17beta-dihydroxyandrost-4- 4000 III N en-3-one) 4-Methoxyamphetamine 7411 I N PMA 4-Methyl-2,5-dimethoxyamphetamine 7395 I N DOM, STP 4-Methylaminorex (cis isomer) 1590 I N U4Euh, McN-422 5-Androstenediol (3beta,17beta-dihydroxy-androst-5- 4000 III N ene) 5-Androstenedione (androst-5-en-3,17-dione) 4000 III N 5-Methoxy-3,4-methylenedioxyamphetamine 7401 I N MMDA 5-Methoxy-N,N-diisopropyltryptamine 7439 I N 5-MeO-DIPT 5-Methoxy-N-N-dimethyltryptamine 7431 I N 5-MeO-DMT Acetorphine 9319 I Y Acetyl-alpha-methylfentanyl 9815 I Y Acetyldihydrocodeine 9051 I Y Acetylcodone Acetylmethadol 9601 I Y Methadyl acetate Alfentanil 9737 II Y Alfenta Allylprodine 9602 I Y Alphacetylmethadol except levo-alphacetylmethadol 9603 I Y Controlled Substances - Alphabetical Order 4/25/2013 Page 2 of 12 DEA CSA SUBSTANCE NUMBER SCH NARC OTHER NAMES Alpha-ethyltryptamine 7249 I N ET, Trip Alphameprodine 9604 I Y Alphamethadol 9605 I Y Alpha-methylfentanyl 9814 I Y China White, fentanyl Alpha-methylthiofentanyl 9832 I Y China White, fentanyl Alpha-methyltryptamine 7432 I N AMT Alphaprodine 9010 II Y Nisentil Alprazolam 2882 IV N Xanax AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) 7201 I N AM-2201 AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) 7694 I N AM-694 Aminorex 1585 I N has been sold as methamphetamine Amobarbital 2125 II N Amytal, Tuinal Amobarbital & noncontrolled active ingred. 2126 III N Amobarbital suppository dosage form 2126 III N Amphetamine 1100 II N Dexedrine, Adderall, Obetrol Anabolic steroids 4000 III N "Body Building" drugs Androstanedione (5alpha-androstan-3,17-dione) 4000 III N Anileridine 9020 II Y Leritine Aprobarbital 2100 III N Alurate Barbital 2145 IV N Veronal, Plexonal, barbitone Barbituric acid derivative 2100 III N Barbiturates not specifically listed Benzethidine 9606 I Y Benzphetamine 1228 III N Didrex, Inapetyl Benzylmorphine 9052 I Y Betacetylmethadol 9607 I Y Beta-hydroxy-3-methylfentanyl 9831 I Y China White, fentanyl Beta-hydroxyfentanyl 9830 I Y China White, fentanyl Betameprodine 9608 I Y Betamethadol 9609 I Y Betaprodine 9611 I Y Bezitramide 9800 II Y Burgodin Bolasterone (7alpha,17alpha-dimethyl-17beta- 4000 III N hydroxyandrost-4-en-3-one) Boldenone (17beta-hydroxyandrost-1,4-diene-3-one) 4000 III N Equipoise, Parenabol, Vebonol, dehydrotestosterone Boldione 4000 III N Bromazepam 2748 IV N Lexotan, Lexatin, Lexotanil Bufotenine 7433 I N Mappine, N,N-dimethylserotonin Buprenorphine 9064 III Y Buprenex, Temgesic, Subutex, Suboxone Controlled Substances - Alphabetical Order 4/25/2013 Page 3 of 12 DEA CSA SUBSTANCE NUMBER SCH NARC OTHER NAMES Butabarbital (secbutabarbital) 2100 III N Butisol, Butibel Butalbital 2100 III N Fiorinal, Butalbital with aspirin Butobarbital (butethal) 2100 III N Soneryl (UK) Butorphanol 9720 IV N Stadol, Stadol NS, Torbugesic, Torbutrol Calusterone (7beta,17alpha-dimethyl-17beta- 4000 III N Methosarb hydroxyandrost-4-en-3-one) Camazepam 2749 IV N Albego, Limpidon, Paxor Carfentanil 9743 II Y Wildnil Carisoprodol 8192 IV N Soma Cathine 1230 IV N Constituent of "Khat" plant, (+)-norpseudoephedrine Cathinone 1235 I N Constituent of "Khat" plant Chloral betaine 2460 IV N Beta Chlor Chloral hydrate 2465 IV N Noctec Chlordiazepoxide 2744 IV N Librium, Libritabs, Limbitrol, SK-Lygen Chlorhexadol 2510 III N Mechloral, Mecoral, Medodorm, Chloralodol Chlorphentermine 1645 III N Pre-Sate, Lucofen, Apsedon, Desopimon Clobazam 2751 IV N Urbadan, Urbanyl Clonazepam 2737 IV N Klonopin, Clonopin Clonitazene 9612 I Y Clorazepate 2768 IV N Tranxene Clortermine 1647 III N Voranil Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one) 4000 III N Alfa-Trofodermin, Clostene, 4-chlorotestosterone Clotiazepam 2752 IV N Trecalmo, Rize, Clozan, Veratran Cloxazolam 2753 IV N Akton, Lubalix, Olcadil, Sepazon Coca Leaves 9040 II Y Cocaine 9041 II Y Methyl benzoylecgonine, Crack Codeine 9050 II Y Morphine methyl ester, methyl morphine Codeine & isoquinoline alkaloid 90 mg/du 9803 III Y Codeine with papaverine or noscapine Codeine combination product 90 mg/du 9804 III Y Empirin,Fiorinal,Tylenol,ASA or APAP w/codeine Codeine methylbromide 9070 I Y Codeine preparations - 200 mg/(100 ml or 100 gm) V Y Cosanyl,Robitussin A-C,Cheracol,Cerose,Pediacof Codeine-N-oxide 9053 I Y CP-47497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- 7297 I N CP-47497 hydroxycyclohexyl-phenol) CP-47497 C8 Homologue (5-(1,1-Dimethyloctyl)-2- 7298 I N CP-47497 C8 Homologue [(1R,3S)3-hydroxycyclohexyl-phenol) Cyprenorphine 9054 I Y Dehydrochloromethyltestosterone (4-chloro-17beta- 4000 III N Oral-Turinabol hydroxy-17alpha-methylandrost-1,4-dien-3-one) Controlled Substances - Alphabetical Order 4/25/2013 Page 4 of 12 DEA CSA SUBSTANCE NUMBER SCH NARC OTHER NAMES Delorazepam 2754 IV N Delta1-dihydrotestosterone (17beta-hydroxy-5alpha- 4000 III N 1-Testosterone androst-1-en-3-one) Desomorphine 9055 I Y Desoxymethyltestosterone 4000 III N Dexfenfluramine 1670 IV N Redux Dextromoramide 9613 I Y Palfium, Jetrium, Narcolo Dextropropoxyphene dosage forms 9278 IV Y Darvon, propoxyphene, Darvocet, Propacet Dextropropoxyphene, bulk (non-dosage forms) 9273 II Y Propoxyphene Diampromide 9615 I Y Diazepam 2765 IV N Valium, Diastat Dichloralphenazone 2467 IV N Midrin, dichloralantipyrine Diethylpropion 1610 IV N Tenuate, Tepanil Diethylthiambutene 9616 I Y Diethyltryptamine 7434 I N DET Difenoxin 9168 I Y Lyspafen Difenoxin 1 mg/25 ug AtSO4/du 9167 IV Y Motofen Difenoxin preparations - 0.5 mg/25 ug AtSO4/du V Y Motofen Dihydrocodeine 9120 II Y Didrate, Parzone Dihydrocodeine combination product 90 mg/du 9807 III Y Synalgos-DC, Compal Dihydrocodeine preparations 10 mg/(100 ml or 100 gm) V Y Cophene-S, various others Dihydroetorphine 9334 II Y DHE Dihydromorphine 9145 I Y Dimenoxadol 9617 I Y Dimepheptanol 9618 I Y Dimethylthiambutene 9619 I Y Dimethyltryptamine 7435 I N DMT Dioxaphetyl butyrate 9621 I Y Diphenoxylate 9170 II Y Diphenoxylate preparations 2.5 mg/25 ug AtSO4 V Y Lomotil, Logen Dipipanone 9622 I Y Dipipan, phenylpiperone HCl, Diconal, Wellconal Dronabinol (synthetic) in sesame oil in soft gelatin 7369 III N Marinol, synthetic THC in sesame oil/soft gelatin
Load more

Recommended publications
  • Backing Material Packaging Liner
    US009314527B2 (12) United States Patent (10) Patent No.: US 9,314,527 B2 Cottrell et al. (45) Date of Patent: *Apr. 19, 2016 (54) TRANSDERMAL DELIVERY PATCH 9/7061 (2013.01); A61K 9/7084 (2013.01); (71) Applicant: Phosphagenics Limited, Clayton, A61 K3I/355 (2013.01); A61K47/24 Victoria (AU) SE7 8E.O. (72) Inventors: Jeremy Cottrell, Caulfield South (AU); ( .01): ( .01): (2013.01) Giacinto Gaetano, South Melbourne (AU); Mahmoud El-Tamimy, Meadow (58) Field of Classification Search Heights (AU); Nicholas Kennedy, None Boronia (AU); Paul David Gavin, See application file for complete search history. Chadstone (AU) (56) References Cited (73) Assignee: Phosphagenics Limited, Victoria (AU) (*) Notice: Subject to any disclaimer, the term of this U.S. PATENT DOCUMENTS patent is extended or adjusted under 35 2,407,823. A 9, 1946 Fieser U.S.C. 154(b) by 0 days. 2.457,932 A 1/1949 Solmssen et al. This patent is Subject to a terminal dis- (Continued) claimer. (21) Appl. No.: 14/550,514 FOREIGN PATENT DOCUMENTS ppl. No.: 9 (22) Filed: Nov. 21, 2014 A 3.3 5.83 (65) Prior Publication Data (Continued) Related U.S. Application Data Gianello et al. Subchronic Oral Toxicity Study of Mixed Tocopheryl (63) Continuation of application No. 14/086,738, filed on Phosphates in Rates, International Journal of Toxicology, 26:475 Nov. 21, 2013, now abandoned, which is a 490; 2007.* continuation of application No. 13/501,500, filed as (Continued) application No. PCT/AU2011/000358 on Mar. 30, 2011, now Pat. No. 8,652,511. Primary Examiner — Robert A Wax (60) Provisional application No.
    [Show full text]
  • Federal Controlled Substances Checklist
    Federal Controlled Substances Checklist Introduction By Norton Tooby & Joseph Justin Rollin We have reprinted here an alphabetical list of all controlled substances forbidden under federal drug laws, taken from the official website of the U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control, at http://www.justice.gov/dea/pubs/scheduling.html. No copyright is asserted to this information. This list changes frequently. The official list is contained at 21 CFR § 1308, as supplemented by final rules published in the Federal Register. The attached checklist of controlled substances has been compiled into one list, and placed in alphabetical order, for ease of reference. If a controlled substance is listed in the federal drug schedules, it triggers deportation, INA § 237(a)(2)(B)(i), 8 U.S.C. § 1227(a)(2)(B)(i), and inadmissibility. INA § 212(a)(2)(A)(i)(II), 8 U.S.C. § 1182(a)(2)(A)(i)II). In addition, there is an aggravated felony defined as illicit trafficking in a controlled substance. INA § 101(a)(43)(B), 8 U.S.C. § 1101(a)(43)(B). The same controlled substance lists apply to this ground of deportation as well. If a drug is not listed on the federal controlled substances schedules, it does not trigger removal under these grounds. In addition, because the government has the burden of proof in deportation removal proceedings by clear and convincing evidence, if the record of conviction is ambiguous as to whether the specific substance involved in the particular case was listed on the federal schedules, the government cannot obtain a deportation removal order on this ground.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al
    USOO8603526B2 (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen et al. (45) Date of Patent: Dec. 10, 2013 (54) PHARMACEUTICAL COMPOSITIONS 2008. O152595 A1 6/2008 Emigh et al. RESISTANT TO ABUSE 2008. O166407 A1 7/2008 Shalaby et al. 2008/0299.199 A1 12/2008 Bar-Shalom et al. 2008/0311205 A1 12/2008 Habib et al. (75) Inventors: Peter Holm Tygesen, Smoerum (DK); 2009/0022790 A1 1/2009 Flath et al. Jan Martin Oevergaard, Frederikssund 2010/0203129 A1 8/2010 Andersen et al. (DK); Karsten Lindhardt, Haslev (DK); 2010/0204259 A1 8/2010 Tygesen et al. Louise Inoka Lyhne-versen, Gentofte 2010/0239667 A1 9/2010 Hemmingsen et al. (DK); Martin Rex Olsen, Holbaek 2010, O291205 A1 11/2010 Downie et al. (DK); Anne-Mette Haahr, Birkeroed 2011 O159100 A1 6/2011 Andersen et al. (DK); Jacob Aas Hoellund-Jensen, FOREIGN PATENT DOCUMENTS Frederikssund (DK); Pemille Kristine Hoeyrup Hemmingsen, Bagsvaerd DE 20 2006 014131 1, 2007 (DK) EP O435,726 8, 1991 EP O493513 7, 1992 EP O406315 11, 1992 (73) Assignee: Egalet Ltd., London (GB) EP 1213014 6, 2002 WO WO 89,09066 10, 1989 (*) Notice: Subject to any disclaimer, the term of this WO WO91,040 15 4f1991 patent is extended or adjusted under 35 WO WO95/22962 8, 1995 U.S.C. 154(b) by 489 days. WO WO99,51208 10, 1999 WO WOOOf 41704 T 2000 WO WO 03/024426 3, 2003 (21) Appl. No.: 12/701,429 WO WOO3,O24429 3, 2003 WO WOO3,O24430 3, 2003 (22) Filed: Feb.
    [Show full text]
  • Control Substance List
    Drugs DrugID SubstanceName DEANumbScheNarco OtherNames 1 1-(1-Phenylcyclohexyl)pyrrolidine 7458 I N PCPy, PHP, rolicyclidine 2 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine 9663 I Y PEPAP, synthetic heroin 3 1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I N TCP, tenocyclidine 4 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 I N TCPy 5 13Beta-ethyl-17beta-hydroxygon-4-en-3-one 4000 III N 6 17Alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane 4000 III N 7 17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane 4000 III N 8 17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene 4000 III N 9 17Alpha-methyl-4-hydroxynandrolone (17alpha-methyl-4-hyd 4000 III N 10 17Alpha-methyl-delta1-dihydrotestosterone (17beta-hydroxy- 4000 III N 17-Alpha-methyl-1-testosterone 11 19-Nor-4-androstenediol (3beta,17beta-dihydroxyestr-4-ene; 4000 III N 12 19-Nor-4-androstenedione (estr-4-en-3,17-dione) 4000 III N 13 19-Nor-5-androstenediol (3beta,17beta-dihydroxyestr-5-ene; 4000 III N 14 19-Nor-5-androstenedione (estr-5-en-3,17-dione) 4000 III N 15 1-Androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1- 4000 III N 16 1-Androstenedione (5alpha-androst-1-en-3,17-dione) 4000 III N 17 1-Methyl-4-phenyl-4-propionoxypiperidine 9661 I Y MPPP, synthetic heroin 18 1-Phenylcyclohexylamine 7460 II N PCP precursor 19 1-Piperidinocyclohexanecarbonitrile 8603 II N PCC, PCP precursor 20 2,5-Dimethoxy-4-(n)-propylthiophenethylamine 7348 I N 2C-T-7 21 2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET 22 2,5-Dimethoxyamphetamine 7396 I N DMA, 2,5-DMA 23 3,4,5-Trimethoxyamphetamine
    [Show full text]
  • BOARD MEETING AGENDA Meeting Location: Portland State Office Building 800 NE Oregon Street, Portland, OR 97232 June 6-7, 2018 Updated 6.4.18
    Oregon Board of Pharmacy BOARD MEETING AGENDA Meeting Location: Portland State Office Building 800 NE Oregon Street, Portland, OR 97232 June 6-7, 2018 Updated 6.4.18 The mission of the Oregon State Board of Pharmacy is to promote, preserve and protect the public health, safety and welfare by ensuring high standards in the practice of pharmacy and by regulating the quality, manufacture, sale and distribution of drugs. Wednesday, June 6, 2018 @ 8:30AM – Conference Rm A Thursday, June 7, 2018 @ 8:30AM – Conference Room A ≈ If special accommodations are needed for you to attend or participate in this Board Meeting, please contact Loretta Glenn at: (971) 673-0001. ≈ WEDNESDAY, JUNE 6, 2018 I. 8:30AM OPEN SESSION, Penny Reher, R.Ph, Presiding A. Roll Call B. Agenda Review and Approval Action Necessary II. Contested Case Deliberation pursuant to ORS 192.690(1) - Not Open to the Public III. EXECUTIVE SESSION – NOT OPEN TO THE PUBLIC, pursuant to ORS 676.175, ORS 192.660 (1) (2) (f) (k). A. Items for Consideration and Discussion: 1. Deliberation on Disciplinary Cases and Investigations 2. Personal Appearances 3. Deficiency Notifications 4. Case Review B. Employee Performance Review pursuant to ORS 192.660(2)(i). IV. OPEN SESSION - PUBLIC MAY ATTEND - At the conclusion of Executive Session, the Board may convene Open Session to begin some of the following scheduled agenda items - time permitting at approximately 3:30PM. V. Approve Consent Agenda* Action Necessary *Items listed under the consent agenda are considered to be routine agency matters and will be approved by a single motion of the Board without separate discussion.
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Chapter 329 [New] Uniform Controlled Substances Act
    CHAPTER 329 [NEW] UNIFORM CONTROLLED SUBSTANCES ACT Part I. General Provisions Section 329-1 Definitions 329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment 329-3 Annual report 329-4 Duties of the commission Part II. Standards and Schedules 329-11 Authority to schedule controlled substances 329-12 Nomenclature 329-13 Schedule I tests 329-14 Schedule I 329-15 Schedule II tests 329-16 Schedule II 329-17 Schedule III Tests 329-18 Schedule III 329-19 Schedule IV tests 329-20 Schedule IV 329-21 Schedule V tests 329-22 Schedule V 329-23 Republishing and distribution of schedules Part III. Regulation of Manufacture, Distribution, Prescription, and Dispensing of Controlled Substances 329-31 Rules 329-31.5 Clinics 329-32 Registration requirements 329-33 Registration 329-34 Revocation and suspension of registration 329-35 Order to show cause 329-36 Records of registrants 329-37 Filing requirements 329-38 Prescriptions 329-39 Labels 329-40 Methadone treatment programs Part IV. Offenses and Penalties 329-41 Prohibited acts B-penalties 329-42 Prohibited acts C-penalties 329-43 Penalties under other laws 329-43.5 Prohibited acts related to drug paraphernalia Amended 0612 1 329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs 329-45 Repealed 329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions 329-49 Administrative penalties 329-50 Injunctive relief Part V. Enforcement and Administrative Provisions 329-51 Powers of enforcement personnel 329-52 Administrative inspections 329-53 Injunctions 329-54 Cooperative arrangements and confidentiality 329-55 Forfeitures 329-56 Burden of proof; liabilities 329-57 Judicial review 329-58 Education and research 329-59 Controlled substance registration revolving fund; established Part VI.
    [Show full text]
  • NIDA Drug Supply Program Catalog, 25Th Edition
    RESEARCH RESOURCES DRUG SUPPLY PROGRAM CATALOG 25TH EDITION MAY 2016 CHEMISTRY AND PHARMACEUTICS BRANCH DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES NATIONAL INSTITUTE ON DRUG ABUSE NATIONAL INSTITUTES OF HEALTH DEPARTMENT OF HEALTH AND HUMAN SERVICES 6001 EXECUTIVE BOULEVARD ROCKVILLE, MARYLAND 20852 160524 On the cover: CPK rendering of nalfurafine. TABLE OF CONTENTS A. Introduction ................................................................................................1 B. NIDA Drug Supply Program (DSP) Ordering Guidelines ..........................3 C. Drug Request Checklist .............................................................................8 D. Sample DEA Order Form 222 ....................................................................9 E. Supply & Analysis of Standard Solutions of Δ9-THC ..............................10 F. Alternate Sources for Peptides ...............................................................11 G. Instructions for Analytical Services .........................................................12 H. X-Ray Diffraction Analysis of Compounds .............................................13 I. Nicotine Research Cigarettes Drug Supply Program .............................16 J. Ordering Guidelines for Nicotine Research Cigarettes (NRCs)..............18 K. Ordering Guidelines for Marijuana and Marijuana Cigarettes ................21 L. Important Addresses, Telephone & Fax Numbers ..................................24 M. Available Drugs, Compounds, and Dosage Forms ..............................25
    [Show full text]
  • Government Gazette
    Government Gazette REPUBLIC OF SOUTH AFRICA Regulation Gazette No. 7636 Vol. 454 Pretoria 10 April 2003 No. 24727 AIDS HELPLINE: 0800-0123-22 Prevention is the cure I STAATSKOERANT, 10 APRIL 2003 No. 24727 3 GOVERNMENT NOTICES GOEWERMENTSKENNISGEWINGS DEPARTMENT OF HEALTH DEPARTEMENT VAN GESONDHEID NO. R. 509 10 April 2003 SCHEDULES The Minister of Health has, in terms of section 22A(2) of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), on the recommendation of the Medicines Control Council, made the Schedulesin the Schedule SCHEDULE I In these Schedules, "the Act" meansthe Medicines and Related SubstancesAct, 1965 (Act No. 101 of 1965) SCHEDULE 0 (a) All substancesreferred to in thisSchedule are excluded when specifically packed, labelled and usedfor - (i) industrialpurposes including the manufacture or compounding of consumer items or products which have no pharmacological oraction medicinal purpose, which are intended to be ingested by man or animals as food, or applied to the body as a cosmetic, and which are approved for such use in terms of the Foodstuffs, Cosmetics and Disinfectants Act, 1972 (Act No. 54 of 1972) or registeredin terms of theFertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947); and (ii)analytical laboratory purposes. (b) All substances referred to in this Schedule include the following: 4 No. 24727 GOVERNMENT GAZETTE, 10 APRIL 2003 (i) The saltsand esters of suchsub2ances,+vhere the existence of such salts and esters is possible; and (ii) All preparationsand mixtures of suchsubstances where such preparations and mixtures arenot expressly excluded. This Schedule includesall substances subject to registration in termsof the Act and which are not listed in anyof the other Schedules.
    [Show full text]
  • Decision of the Government of the Russian Federation No
    DECISION OF THE GOVERNMENT OF THE RUSSIAN FEDERATION NO. 681 OF JUNE 30, 1998 ON THE APPROVAL OF THE LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS THAT SHALL BE SUBJECT TO CONTROL IN THE RUSSIAN FEDERATION In accordance with the Federal Law on Narcotic Drugs and Psychotropic Substances (Sobraniye zakonodatelstva Rossiyskoy Federatsii, 1998, No. 2, item 219) the Government of the Russian Federation resolves: To approve the annexed enumeration of narcotic drugs, psychotropic substances and their precursors that shall be subject to control in the Russian Federation. To establish that the amendment of the said enumeration shall be carried out on presentation of the Ministry of Public Health of the Russian Federation jointly with the Ministry of Internal Affairs of the Russian Federation. Chairman of the Government of the Russian Federation Sergey Kirienko Enumeration of Narcotic Drugs, Psychotropic Substances and Their Precursors That Shall Be Subject to Control in the Russian Federation (Approved by the Decision of the Government of the Russian Federation No. 681 of June 30, 1998) List of Narcotic Drugs and Psychotropic Substances Whose Circulation in the Russian Federation Is Prohibited in Accordance with the Legislation of the Russian Federation and the International Treaties of the Russian Federation (List I) List of Narcotic Drugs and Psychotropic Substances Whose Circulation in the Russian Federation Is Restricted and in Whose Respect Control Measures Shall Be Established in Accordance with the Legislation of
    [Show full text]
  • Schedules of Controlled Substances (.Pdf)
    PURSUANT TO THE TEXAS CONTROLLED SUBSTANCES ACT, HEALTH AND SAFETY CODE, CHAPTER 481, THESE SCHEDULES SUPERCEDE PREVIOUS SCHEDULES AND CONTAIN THE MOST CURRENT VERSION OF THE SCHEDULES OF ALL CONTROLLED SUBSTANCES FROM THE PREVIOUS SCHEDULES AND MODIFICATIONS. This annual publication of the Texas Schedules of Controlled Substances was signed by John Hellerstedt, M.D., Commissioner of Health, and will take effect 21 days following publication of this notice in the Texas Register. Changes to the schedules are designated by an asterisk (*). Additional information can be obtained by contacting the Department of State Health Services, Drugs and Medical Devices Unit, P.O. Box 149347, Austin, Texas 78714-9347. The telephone number is (512) 834-6755 and the website address is http://www.dshs.texas.gov/dmd. SCHEDULES Nomenclature: Controlled substances listed in these schedules are included by whatever official, common, usual, chemical, or trade name they may be designated. SCHEDULE I Schedule I consists of: -Schedule I opiates The following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, if the existence of these isomers, esters, ethers, and salts are possible within the specific chemical designation: (1) Acetyl-α-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) (Other name:
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]